- As the Thai government races to secure more COVID-19 vaccines from various sources, a group of medical scientists is preparing for the first clinical trial of a home-grown cure they are developing to fight the pandemic.
- In April, they expect to inject 72 volunteers aged between 18 and 75 with ChulaCov19 – a vaccine that is being developed by the Medicine Faculty of Chulalongkorn University in Bangkok to fight the infectious disease.
- Globally, there are several types of vaccine technologies being used for COVID-19. ChulaCov19 employs Messenger RNA or mRNA, which enables the body to produce a protein that triggers an immune response to the virus.
- The technology is used by leading pharmaceutical companies such as Moderna, Pfizer and BioNTech.
- “We chose mRNA because we believe it is a technology of the future. It has also been proven that this technology developed the fastest and reported 94 per cent to 95 per cent efficacy in humans, which is the highest rate,” Kiat told CNA.
What is your plan for crisis control? Need help managing your organization crisis? Each crisis is different, if you have a crisis contact us immediately at https://www.crisismanagementcentre.com/contact-us/
We are ready to manage your crisis.